EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

Lucas de Villalaín, Saúl Álvarez-Teijeiro iD, Tania Rodríguez-Santamarta, Álvaro Fernández Del Valle, Eva Allonca iD, Juan P Rodrigo iD, Juan Carlos de Vicente iD, Juana M García-Pedrero iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lucas de Villalaín und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de A…. Hauptthemen laut MEDLINE: Precancerous Conditions, Mouth Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, CIBERONC, FEDER Funding Program from the European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate the expression of the senescence markers, Decoy Receptor 2 (DcR2) and Differentiated Embryo-Chondrocyte expressed gen 1 (DEC1), in oral potentially malignant disorders (OPMDs) to ascertain their possible association with oral cancer risk. The immunohistochemical analysis of DcR2 and DEC1 expression (along with p16 and Ki67 expression) was carried out in 60 patients with clinically diagnosed oral leukoplakia. Fifteen cases (25%) subsequently developed an invasive carcinoma. Correlations between protein marker expression, histological grade and oral cancer risk were assessed. DcR2, DEC1 and Ki67 protein expressions were found to correlate significantly with increased oral cancer risk, and also with an increased grade of dysplasia. Multivariate analysis demonstrated that DcR2 and Ki67 expression are independent predictors of oral cancer development. Our results evidence for the first time the potential of DcR2 as an early biomarker to assess oral cancer risk in patients with oral leukoplakia (HR = 59.7, p = 0.015), showing a superior predictive value to histology (HR = 4.225, p = 0.08). These findings reveal that the increased expression of DcR2 and DEC1 occurred frequently in OPMDs. In addition, DcR2 expression emerges as a powerful biomarker for oral cancer risk assessment in patients with oral leukoplakia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precancerous ConditionsMouth NeoplasmsHumansKi-67 AntigenLeukoplakia, OralHyperplasia

Stichwörter der Autor:innen

DEC1DcR2Ki67cancer risk markeroral leukoplakiaoral potentially malignant disorderssenescence

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Asturias, Spain.
  • Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Asturias, Spain.
  • Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, 33006 Oviedo, Asturias, Spain.
  • CIBER de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Saúl Álvarez-Teijeiro, Eva Allonca, Juan P Rodrigo, Juan Carlos de Vicente, Juana M García-Pedrero

Förderung

  • Instituto de Salud Carlos III
  • CIBERONC
  • FEDER Funding Program from the European Union
  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)
  • Fundación Bancaria Cajastur-IUOPA
  • Universidad de Oviedo
  • Ayudas para Grupos de Investigación de Organismos del Principado de Asturias 2021–2023
  • Principado de Asturias through FICYT

Zitieren

APA

de Villalaín, L., Álvarez-Teijeiro, S., Rodríguez-Santamarta, T., Fernández Del Valle, Á., Allonca, E., Rodrigo, J. P., de Vicente, J. C., & García-Pedrero, J. M. (2023). Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814382

Vancouver

de Villalaín L, Álvarez-Teijeiro S, Rodríguez-Santamarta T, Fernández Del Valle Á, Allonca E, Rodrigo JP, et al. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814382

BibTeX
@article{deVillalan2023,
  author = {de Villalaín, Lucas and Álvarez-Teijeiro, Saúl and Rodríguez-Santamarta, Tania and Fernández Del Valle, Álvaro and Allonca, Eva and Rodrigo, Juan P and de Vicente, Juan Carlos and García-Pedrero, Juana M},
  title = {Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814382}
}
Kostenlos starten →